Currently, there are 350.14M common shares owned by the public and among those 347.40M shares have been available to trade.
The company’s stock has a 5-day price change of -2.18% and 54.29% over the past three months. HBI shares are trading 61.21% year to date (YTD), with the 12-month market performance up to 90.72% higher. It has a 12-month low price of $3.58 and touched a high of $7.41 over the same period. HBI has an average intraday trading volume of 8.78 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 5.27%, 12.57%, and 37.38% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Hanesbrands Inc (NYSE: HBI) shares accounts for 95.16% of the company’s 350.14M shares outstanding.
It has a market capitalization of $2.53B and a beta (3y monthly) value of 1.58. The earnings-per-share (ttm) stands at -$0.85. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.89% over the week and 3.58% over the month.
Earnings per share for the fiscal year are expected to increase by 481.17%, and 63.37% over the next financial year.
Looking at the support for the HBI, a number of firms have released research notes about the stock. Credit Suisse stated their Neutral rating for the stock in a research note on November 10, 2022, with the firm’s price target at $10-$7. Wells Fargo coverage for the Hanesbrands Inc (HBI) stock in a research note released on October 31, 2022 offered a Underweight rating with a price target of $5. Evercore ISI was of a view on July 13, 2022 that the stock is In-line, while Barclays gave the stock Equal Weight rating on June 08, 2022, issuing a price target of $18- $13. Stifel on their part issued Hold rating on May 06, 2022.
